Lisata Therapeutics LSTA
NASDAQ LSTA
$1.47 -0.02 (-1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lisata Therapeutics (LSTA) Cash & Equivalents (2010 - 2026)

Updated

Lisata Therapeutics (LSTA) recorded Cash & Equivalents of $10.44 million in Q2 2026, down 38.0% from $16.84 million a year earlier and down 20.3% from the prior quarter.

Analysis

Lisata Therapeutics (LSTA) Cash & Equivalents (2010 - 2026) Analysis & Trends

At the end of FY2025, Lisata Therapeutics reported Cash & Equivalents of $15.96 million, down 1.6% from FY2024.

  • Annual Cash & Equivalents has declined for three straight years, with a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
  • Across earlier years, Cash & Equivalents came in at $16.21 million in FY2024 (-28.3%), $22.59 million in FY2023 (-29.7%), $32.15 million in FY2022 (+30.5%) and $24.65 million in FY2021 (+49.3%).
  • The Q2 2026 figure is the lowest quarterly Cash & Equivalents since Q4 2018.
  • On a year-over-year basis, Cash & Equivalents has declined for eight consecutive quarters, with an average decline of 24.2% over the last eight quarters.
  • Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 157.8% in Q2 2022, against a decline of 55.7% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $13.1 million (Q1 2026), $15.96 million (Q4 2025) and $19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Lisata Therapeutics 13.59 Mn 13.33 Mn - 10.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.44 Mn
Mar 31, 2026 13.10 Mn
Dec 31, 2025 15.96 Mn
Sep 30, 2025 19.00 Mn
Jun 30, 2025 16.84 Mn
Mar 31, 2025 20.22 Mn
Dec 31, 2024 16.21 Mn
Sep 30, 2024 19.51 Mn
Jun 30, 2024 28.29 Mn
Mar 31, 2024 21.81 Mn
Dec 31, 2023 22.59 Mn
Sep 30, 2023 32.43 Mn
Jun 30, 2023 23.69 Mn
Mar 31, 2023 28.16 Mn
Dec 31, 2022 32.15 Mn
Sep 30, 2022 31.48 Mn
Jun 30, 2022 33.35 Mn
Mar 31, 2022 12.75 Mn
Dec 31, 2021 24.65 Mn
Sep 30, 2021 12.77 Mn
API Access

Lisata Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LSTA&period=max&api_key=YOUR_API_KEY